Exhibit 99.1

news     

INVESTOR CONTACT:	FOR IMMEDIATE RELEASE MEDIA CONTACT:
Mark Kimbrough 615-344-2688	Ed Fishbough 615-344-2810

HCA Reports Second Quarter 2009 Results

Nashville, Tenn., July 29, 2009 — HCA Inc. today announced financial and operating results for its second quarter ended June 30, 2009.

Second Quarter Summary:

• Revenues increased 7.2 percent to $7.483 billion.

• Net income attributable to HCA Inc. totaled $282 million, compared to $141 million in the prior year’s second quarter.

• Adjusted EBITDA totaled $1.399 billion, compared to $1.104 billion in the second quarter of 2008.

• Provision for doubtful accounts totaled $866 million, compared to $813 million in the prior year.

• Interest expense increased to $506 million from $494 million in the prior year’s second quarter.

• Same facility equivalent admissions increased 4.4 percent, while same facility admissions increased 1.9 percent in the second quarter compared to the same period last year.

• Same facility revenue per equivalent admission increased 3.0 percent.

• Total surgeries, on a same facility basis, increased 0.1 percent from the prior year’s second quarter.

Revenues for the second quarter totaled $7.483 billion, compared to $6.980 billion in the second quarter of 2008. Adjusted EBITDA in the quarter totaled $1.399 billion, compared to $1.104 billion in the previous year’s second quarter. A table describing adjusted EBITDA and reconciling net income attributable to HCA Inc. to adjusted EBITDA for these periods is included in this release. Net income attributable to HCA Inc. for the second quarter of 2009 totaled $282 million, compared to $141 million in the prior year’s second quarter. Results for the second quarter of 2009 include losses on sales of facilities of $3 million compared to losses of $11 million in the second quarter of 2008. Second quarter 2009 results also include a $4 million charge for impairment of long-lived assets compared to an impairment charge of $9 million in the second quarter of 2008.

The provision for doubtful accounts increased to $866 million, or 11.6 percent of revenues, in the second quarter of 2009 from $813 million, or 11.7 percent of revenues, in the second quarter of 2008, primarily due to an increase in uninsured admissions. Same facility uninsured admissions increased 10.4 percent in the second quarter of 2009 compared to the prior year’s second quarter. Same facility charity care and

1

uninsured discounts totaled $1.158 billion in the second quarter of 2009 compared to $846 million in the second quarter of 2008.

During the second quarter of 2009, salaries and benefits, supply expense and other operating expenses totaled $5.279 billion compared to $5.125 billion in the second quarter of 2008, a decline of 2.9 percent as a percent of revenues.

Interest expense increased to $506 million in the second quarter of 2009, compared to $494 million in the same period of 2008, due primarily to a slight increase in the average interest rate on our outstanding debt.

Same facility admissions increased 1.9 percent and same facility equivalent admissions increased 4.4 percent in the second quarter of 2009 compared to the prior year’s second quarter. Same facility inpatient surgeries increased 0.5 percent and same facility outpatient surgeries declined 0.2 percent in the second quarter. Same facility revenue per equivalent admission increased 3.0 percent in the second quarter of 2009 compared to the second quarter of 2008.

Revenues for the six months ended June 30, 2009 totaled $14.914 billion compared to $14.107 billion for the same period of 2008. Adjusted EBITDA totaled $2.856 billion for the first half of 2009 compared to $2.284 billion for the same period of 2008. Net income attributable to HCA Inc. was $642 million for the six months ended June 30, 2009 compared to $311 million in the prior year. Results for the six months ended June 30, 2009 include losses on sales of facilities of $8 million and an impairment of long-lived assets of $13 million compared to gains on sales of facilities of $40 million and an impairment of long-lived assets of $9 million in the first half of 2008.

Cash flows from operating activities increased $691 million, from $424 million for the six months ended June 30, 2008 to $1.115 billion for the six months ended June 30, 2009. The increase was due primarily to the $375 million increase in net income and $312 million improvement from changes in operating assets and liabilities and the provision for doubtful accounts.

As of June 30, 2009, HCA’s balance sheet reflected cash and cash equivalents of $450 million, total debt of $26.545 billion, and total assets of $24.241 billion. During the second quarter of 2009, capital expenditures totaled $282 million, excluding acquisitions. For the six months ended June 30, 2009, capital expenditures totaled $619 million, excluding acquisitions.

As of June 30, 2009, HCA operated 163 hospitals and 105 freestanding surgery centers (including eight hospitals and eight freestanding surgery centers operated through equity method joint ventures).

Earnings Conference Call

HCA will host a conference call for investors at 9:00 a.m. Central Daylight Time today. The dial in number for today’s call is 888-359-3627 (no code required). A live audio broadcast of the call via webcast will also be available to investors. The broadcast will be available on a replay basis beginning this afternoon. The webcast can be accessed at: http://www.videonewswire.com/event.asp?id=60459 or through the Company’s Investor Relations web page, www.hcahealthcare.com.

2

Cautionary Statement about Preliminary Results and Other Forward-Looking Information

This press release contains forward-looking statements based on current management expectations. Those forward-looking statements include all statements other than those made solely with respect to historical fact. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those expressed in any forward-looking statements. These factors include, but are not limited to, (1) the ability to recognize the benefits of the Recapitalization, (2) the impact of the substantial indebtedness incurred to finance the Recapitalization and the ability to refinance such indebtedness on acceptable terms, (3) the possible enactment of federal or state health care reform and changes in federal, state or local laws or regulations affecting the health care industry, (4) increases, particularly in the current economic downturn, in the amount and risk of collectibility of uninsured accounts and deductibles and copayment amounts for insured accounts, (5) the ability to achieve operating and financial targets, and attain expected levels of patient volumes and control the costs of providing services, (6) possible changes in the Medicare, Medicaid and other state programs, including Medicaid supplemental payments pursuant to upper payment limit (“UPL”) programs, that may impact reimbursements to health care providers and insurers, (7) the highly competitive nature of the health care business, (8) changes in revenue mix, including potential declines in the population covered under managed care agreements due to the current economic downturn and the ability to enter into and renew managed care provider agreements on acceptable terms, (9) the efforts of insurers, health care providers and others to contain health care costs, (10) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (11) increases in wages and the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical and technical support personnel, (12) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (13) changes in accounting practices, (14) changes in general economic conditions nationally and regionally in our markets, (15) future divestitures which may result in charges, (16) changes in business strategy or development plans, (17) delays in receiving payments for services provided, (18) the outcome of pending and any future tax audits, appeals and litigation associated with our tax positions, (19) potential liabilities and other claims that may be asserted against us, and (20) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2008 and other filings with the Securities and Exchange Commission. Many of the factors that will determine our future results are beyond our ability to control or predict. In light of the significant uncertainties inherent in the forward-looking statements contained herein, readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

3

HCA Inc.
Condensed Consolidated Income Statements
Second Quarter
(Dollars in millions)

	2009						2008
	Amount			Ratio			Amount			Ratio
Revenues	$	7,483			100.0	%	$	6,980			100.0	%
Salaries and benefits		2,944			39.3			2,841			40.7
Supplies		1,211			16.2			1,149			16.5
Other operating expenses		1,124			15.0			1,135			16.2
Provision for doubtful accounts		866			11.6			813			11.7
Equity in earnings of affiliates		(61	)		(0.8	)		(62	)		(0.9	)
Depreciation and amortization		360			4.8			355			5.0
Interest expense		506			6.8			494			7.1
Losses on sales of facilities		3			—			11			0.2
Impairment of long-lived assets		4			0.1			9			0.1
		6,957			93.0			6,745			96.6
Income before income taxes		526			7.0			235			3.4
Provision for income taxes		161			2.1			38			0.6
Net income		365			4.9			197			2.8
Net income attributable to noncontrolling interests		83			1.1			56			0.8
Net income attributable to HCA Inc.	$	282			3.8		$	141			2.0

4

HCA Inc.
Condensed Consolidated Income Statements
For the Six Months Ended June 30, 2009 and 2008
(Dollars in millions)

	2009						2008
	Amount			Ratio			Amount			Ratio
Revenues	$	14,914			100.0	%	$	14,107			100.0	%
Salaries and benefits		5,867			39.3			5,680			40.3
Supplies		2,421			16.2			2,322			16.5
Other operating expenses		2,226			15.1			2,249			15.8
Provision for doubtful accounts		1,673			11.2			1,701			12.1
Equity in earnings of affiliates		(129	)		(0.9	)		(129	)		(0.9	)
Depreciation and amortization		713			4.7			712			5.0
Interest expense		977			6.5			1,024			7.3
Losses (gains) on sales of facilities		8			0.1			(40	)		(0.3	)
Impairment of long-lived assets		13			0.1			9			0.1
		13,769			92.3			13,528			95.9
Income before income taxes		1,145			7.7			579			4.1
Provision for income taxes		348			2.4			157			1.1
Net income		797			5.3			422			3.0
Net income attributable to noncontrolling interests		155			1.0			111			0.8
Net income attributable to HCA Inc.	$	642			4.3		$	311			2.2

5

HCA Inc.
Supplemental Operating Results Summary
(Dollars in millions)

					For the Six Months
	Second Quarter				Ended June 30,
	2009		2008		2009		2008
Revenues	$	7,483	$	6,980	$	14,914	$	14,107
Net income attributable to HCA Inc.	$	282	$	141	$	642	$	311
Losses (gains) on sales of facilities (net of tax)		2		6		5		(24	)
Impairment of long-lived assets (net of tax)		2		6		8		6
Net income attributable to HCA Inc., excluding losses (gains) on sales of facilities and impairment of long-lived assets		286		153		655		293
Depreciation and amortization		360		355		713		712
Interest expense		506		494		977		1,024
Provision for income taxes		164		46		356		144
Net income attributable to noncontrolling interests		83		56		155		111
Adjusted EBITDA (a)	$	1,399	$	1,104	$	2,856	$	2,284

(a)	Net income attributable to HCA Inc., excluding losses (gains) on sales of facilities and impairment of long-lived assets and adjusted EBITDA are non-GAAP financial measures. We believe that net income attributable to HCA Inc., excluding losses (gains) on sales of facilities and impairment of long-lived assets and adjusted EBITDA are important measures that supplement discussions and analysis of our results of operations. We believe that it is useful to investors to provide disclosures of our results of operations on the same basis as that used by management. Management relies upon net income attributable to HCA Inc., excluding losses (gains) on sales of facilities and impairment of long-lived assets and adjusted EBITDA as the primary measures to review and assess operating performance of its hospital facilities and their management teams.
	Management and investors review both the overall performance (including; net income attributable to HCA Inc., excluding losses (gains) on sales of facilities and impairment of long-lived assets and GAAP net income attributable to HCA Inc.) and operating performance (adjusted EBITDA) of our health care facilities. Adjusted EBITDA and the adjusted EBITDA margin (adjusted EBITDA divided by revenues) are utilized by management and investors to compare our current operating results with the corresponding periods during the previous year and to compare our operating results with other companies in the health care industry. It is reasonable to expect that losses (gains) on sales of facilities and impairments of long-lived assets will occur in future periods, but the amounts recognized can vary significantly from period to period, do not directly relate to the ongoing operations of our health care facilities and complicate period comparisons of our results of operations and operations comparisons with other health care companies.
	Net income attributable to HCA Inc., excluding losses (gains) on sales of facilities and impairment of long-lived assets and adjusted EBITDA are not measures of financial performance under accounting principles generally accepted in the United States, and should not be considered as alternatives to net income attributable to HCA Inc. as a measure of operating performance or cash flows from operating, investing and financing activities as a measure of liquidity. Because net income attributable to HCA Inc., excluding losses (gains) on sales of facilities and impairment of long-lived assets and adjusted EBITDA are not measurements determined in accordance with generally accepted accounting principles and are susceptible to varying calculations, net income attributable to HCA Inc., excluding losses (gains) on sales of facilities and impairment of long-lived assets and adjusted EBITDA, as presented, may not be comparable to other similarly titled measures presented by other companies.

6

HCA Inc.
Condensed Consolidated Balance Sheets
(Dollars in millions)

	June 30,			March 31,			December 31,
	2009			2009			2008
ASSETS
Current assets:
Cash and cash equivalents	$	450		$	356		$	465
Accounts receivable, less allowance for doubtful accounts		3,680			3,870			3,780
Inventories		730			717			737
Deferred income taxes		1,032			988			914
Other		556			558			405
Total current assets		6,448			6,489			6,301
Property and equipment, at cost		24,185			23,913			23,714
Accumulated depreciation		(12,752	)		(12,458	)		(12,185	)
		11,433			11,455			11,529
Investments of insurance subsidiary		1,322			1,302			1,422
Investments in and advances to affiliates		854			860			842
Goodwill		2,594			2,579			2,580
Deferred loan costs		444			452			458
Other		1,146			1,147			1,148
	$	24,241		$	24,284		$	24,280
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	1,206		$	1,200		$	1,370
Accrued salaries		876			823			854
Other accrued expenses		1,119			1,458			1,282
Long-term debt due within one year		194			416			404
Total current liabilities		3,395			3,897			3,910
Long-term debt		26,351			26,151			26,585
Professional liability risks		1,108			1,098			1,108
Income taxes and other liabilities		1,713			1,853			1,782
Total liabilities		32,567			32,999			33,385
Equity securities with contingent redemption rights		155			154			155
EQUITY (DEFICIT)
HCA Inc. stockholders’ deficit		(9,486	)		(9,888	)		(10,255	)
Noncontrolling interests		1,005			1,019			995
Total deficit		(8,481	)		(8,869	)		(9,260	)
	$	24,241		$	24,284		$	24,280

7

HCA Inc.
Condensed Consolidated Statements of Cash Flows
For the Six Months Ended June 30, 2009 and 2008
(Dollars in millions)

	2009			2008
Cash flows from operating activities:
Net income	$	797		$	422
Adjustments to reconcile net income to net cash provided by operating activities:
Change in operating assets and liabilities		(1,654	)		(1,994	)
Provision for doubtful accounts		1,673			1,701
Depreciation and amortization		713			712
Income taxes		(417	)		(376	)
Losses (gains) on sales of facilities		8			(40	)
Impairment of long-lived assets		13			9
Change in noncontrolling interests		(159	)		(96	)
Amortization of deferred loan costs		60			43
Pay-in-kind interest		58			—
Share-based compensation		14			19
Other		9			24
Net cash provided by operating activities		1,115			424
Cash flows from investing activities:
Purchase of property and equipment		(619	)		(717	)
Acquisition of hospitals and health care entities		(41	)		(44	)
Disposition of hospitals and health care entities		29			110
Change in investments		71			(11	)
Other		11			13
Net cash used in investing activities		(549	)		(649	)
Cash flows from financing activities:
Issuance of long-term debt		1,751			4
Net change in revolving bank credit facility		(505	)		900
Repayment of long-term debt		(1,782	)		(703	)
Payment of debt issuance costs		(45	)		—
Other		—			(1	)
Net cash (used in) provided by financing activities		(581	)		200
Change in cash and cash equivalents		(15	)		(25	)
Cash and cash equivalents at beginning of period		465			393
Cash and cash equivalents at end of period	$	450		$	368
Interest payments	$	822		$	1,007
Income tax payments, net of refunds	$	765		$	533

8

HCA Inc.
Operating Statistics

							For the Six Months
	Second Quarter						Ended June 30,
	2009			2008			2009			2008
Consolidating Hospitals:
Number of Hospitals		155			161			155			161
Weighted Average Licensed Beds		38,817			38,419			38,814			38,413
Licensed Beds at End of Period		38,793			38,448			38,793			38,448
Reported:
Admissions		387,400			382,600			783,600			784,300
% Change		1.2	%					-0.1	%
Equivalent Admissions		609,900			587,600			1,220,100			1,188,900
% Change		3.8	%					2.6	%
Revenue per Equivalent Admission	$	12,270		$	11,878		$	12,224		$	11,865
% Change		3.3	%					3.0	%
Inpatient Revenue per Admission	$	11,577		$	11,175		$	11,522		$	11,193
% Change		3.6	%					2.9	%
Patient Days		1,872,500			1,887,600			3,825,600			3,912,200
Equivalent Patient Days		2,948,700			2,900,100			5,956,400			5,930,900
Inpatient Surgery Cases		124,400			125,000			247,000			250,400
% Change		-0.5	%					-1.4	%
Outpatient Surgery Cases		200,200			202,100			394,600			399,000
% Change		-0.9	%					-1.1	%
Emergency Room Visits		1,398,000			1,297,600			2,757,700			2,666,400
% Change		7.7	%					3.4	%
Outpatient Revenues as a Percentage of Patient Revenues		39.1	%		37.7	%		38.5	%		36.7	%
Average Length of Stay		4.8			4.9			4.9			5.0
Occupancy		53.0	%		54.0	%		54.5	%		56.0	%
Equivalent Occupancy		83.5	%		82.9	%		84.9	%		84.9	%
Same Facility:
Admissions		380,700			373,800			769,800			766,200
% Change		1.9	%					0.5	%
Equivalent Admissions		598,800			573,400			1,197,000			1,160,000
% Change		4.4	%					3.2	%
Revenue per Equivalent Admission	$	12,253		$	11,891		$	12,214		$	11,878
% Change		3.0	%					2.8	%
Inpatient Revenue per Admission	$	11,600		$	11,218		$	11,556		$	11,231
% Change		3.4	%					2.9	%
Inpatient Surgery Cases		122,500			121,900			243,700			243,300
% Change		0.5	%					0.1	%
Outpatient Surgery Cases		198,100			198,500			389,700			392,000
% Change		-0.2	%					-0.6	%
Emergency Room Visits		1,364,900			1,258,400			2,686,800			2,584,500
% Change		8.5	%					4.0	%
Number of Consolidating and Nonconsolidating (Equity Joint Ventures) Hospitals:
Consolidating		155			161			155			161
Nonconsolidating (Equity Joint Ventures)		8			8			8			8
Total Number of Hospitals		163			169			163			169

9